Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

NCT00070278 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: cyclophosphamide
DRUG: epirubicin hydrochloride
DRUG: gemcitabine hydrochloride
DRUG: paclitaxel
GENETIC: comparative genomic hybridization
GENETIC: microarray analysis
GENETIC: mutation analysis
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy

Sponsor

Cambridge University Hospitals NHS Foundation Trust